A new Cochrane review confirms that antidepressants effectively reduce symptoms of generalized anxiety disorder (GAD) under trial conditions, although there is limited data on long-term usage.

Studies have shown that selective DOP agonists (compounds that activate DOP), such as SNC80 and KNT-127, exert antidepressant and anxiolytic effects (anti-anxiety) in animal models. However ...

A new Cochrane review confirms that antidepressants effectively reduce symptoms of generalized anxiety disorder (GAD) under trial conditions, although there is limited data on long-term usage.